Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kalyan Dadireddy

Plastic Surgery Gainesville, FL Medical Doctor

NPI 1760823595 CMS profile 1378438

1600 Sw Archer Rd, Gainesville, FL 32610

Open in the dashboard

General payments

$4,609

72 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$42,977 paid to institutions, not to them · program year 2025

Through program year 2025, Kalyan Dadireddy of Gainesville, FL is reported in the CMS Open Payments database as having received $4,609 across 72 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $42,977 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 69th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $517 7
2024 General $773 11
2023 General $303 3
2022 General $1,216 5
2021 General $741 34
2020 General $156 2
2019 General $903 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kalyan Dadireddy
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Kalyan Dadireddy were reported at $517. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Kalyan Dadireddy Plastic Surgery median Middle half National median
2019 $903 $371 $122–$1,483 $163
2020 $156 $158 $52–$438 $114
2021 $741 $249 $87–$752 $132
2022 $1,216 $274 $102–$793 $149
2023 $303 $299 $113–$891 $160
2024 $773 $361 $124–$1,062 $164
2025 $517 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sientra, Inc. $1,305 5 payments
  2. PolyNovo North America LLC $857 13 payments
  3. AbbVie, Inc. $757 14 payments
  4. Medline Industries, Inc. $693 7 payments
  5. Allergan Inc. $178 2 payments
  6. Alafair Biosciences,Inc. $140 1 payment
  7. Acell, Inc. $123 1 payment
  8. Kerecis Limited $122 1 payment
  9. Smith+Nephew, Inc. $120 8 payments
  10. Avita Medical Americas, LLC $114 10 payments
  11. Other $202 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,664 70 payments
  2. Travel and Lodging $946 2 payments
Products named General payments · program years 2019–2025
  1. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $1,305 5 payments
  2. NOVOSORB BTM $766 12 payments
  3. NATRELLE SALINE-FILLED BREAST IMPLANTS $361 5 payments
  4. Hyalomatrix Wound Device $308 3 payments
  5. PluroGel Burn & Wound Dressings $308 3 payments
  6. ALLODERM $274 2 payments
  7. Dermatology and Wound Care $221 2 payments
  8. VersaWrap $140 1 payment
  9. DALVANCE $139 4 payments
  10. Kerecis Omega3 Wound $122 1 payment
  11. Other $1,380 44 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$35,157

Medicare's payments for the services billed

Medicare patients

63

Average age 69

Services billed

131

51 women, 12 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Arthritis 54%
Cancer 48%
Diabetes 37%
Ischemic heart disease 25%
Chronic kidney disease 25%
Depression 25%
Atrial fibrillation 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

72 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record